Table 3 The comparison between survivors and non-survivors.
From: Prognosis of alcohol-associated lactic acidosis in critically ill patients: an 8-year study
Characteristics | Survivors Median/IRQ (min~max) | Non- survivors Median$ (min~max) | p |
|---|---|---|---|
No. of patients | 21 | 2 | |
Age (years) | 51.0/10.5 (32–78) | 45.5 (40–51) | 0.561 |
Sex, male, n (%) | 20 (95.2%) | 2 (100%) | 1.000 |
APACHE II score | 14.0/10 (7–33) | 20.5 (17–24) | 0.176 |
Peak lactate level (mmol/L) | 17.8/8.8 (9.7–35.8) | 14.6 (13.3–15.9) | 0.711 |
Lactate clearance rate per hour | 7.4/6.9 (3.0–25.3) | 3.5 (2.8–4.3) | 0.047* |
Nadir arterial pH | 7.2/0.3 (6.8–7.5) | 7.45 (7.4–7.5) | 0.042* |
Nadir arterial bicarbonate level (mmol/L) | 8.2/8.5 (2.3–21.1) | 15.5 (13.3–17.6) | 0.158 |
Detectable blood or urine ketone body, n (%) | 15 (78.9%) | 0 (0%) | 0.250 |
Detectable serum alcohol level, n (%) | 10 (71.4%) | — | — |
Hypoglycemia, n (%) | 2 (9.5%) | 0 (0%) | 1.000 |
Hyperammonemia, n (%) | 15 (71.4%) | 2 (100%) | 1.000 |
High MCV, n (%) | 13 (61.9%) | 1 (50%) | 1.000 |
Gastrointestinal bleeding, n (%) | 4 (19%) | 1 (50%) | 0.395 |
Sepsis, n (%) | 9 (42.9%) | 2 (100%) | 0.217 |
Acute kidney injury, n (%) | 15 (71.4%) | 1 (50%) | 0.526 |
Chronic kidney disease, n (%) | 2 (9.5%) | 0 (0%) | 1.000 |
Liver cirrhosis, n (%) | 7 (33.3%) | 2 (100%) | 0.142 |
Hepatitis, n (%) | 4 (19%) | 0 (0%) | 1.000 |
Vasoactive support, n (%) | 3 (14.3%) | 0 (0%) | 1.000 |
Mechanical ventilation support, n (%) | 0 (0%) | 2 (100%) | <0.05* |
Renal replacement therapy, n (%) | 1 (4.8%) | 0 (100%) | 1.000 |
